Operational Complexity in Cell and Gene Therapy Trials
As advanced therapy technology and manufacturing evolve, there are three key operational challenges to address unique to these products.
Top Three Sources of Operational Complexity in Cell and Gene Therapy Clinical Trials
Erin Finot, Global Head of Immuno-Oncology at IQVIA Biotech, discusses the immense challenges to overcome before advanced therapies become more widespread.
2 Clarke Drive Cranbury, NJ 08512